The CLEC-16A Activators belong to a distinct chemical class characterized by their ability to modulate the activity of the C-type lectin domain family 16A (CLEC-16A). CLEC-16A is a transmembrane protein predominantly expressed in immune cells, and its activation is implicated in various cellular processes, particularly those associated with the immune response. The activators of CLEC-16A are designed to interact with specific binding sites on the CLEC-16A protein, triggering conformational changes that lead to altered cellular signaling cascades.
Structurally, CLEC-16A Activators often possess unique chemical motifs that enable selective recognition and binding to the target protein. These compounds may exhibit diverse pharmacophores, enabling them to engage with specific residues in the CLEC-16A binding pocket. The mechanism of action involves the induction of a conformational shift in CLEC-16A, which may result in downstream effects on intracellular signaling pathways. The study of CLEC-16A Activators contributes to our understanding of the intricate regulatory mechanisms governing immune responses, shedding light on potential targets for further exploration in the broader context of cellular biology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Broad-spectrum protein kinase inhibitor (directly or indirectly activates CLEC-16A through modulation of protein kinase activity). | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Inhibitor of protein tyrosine phosphatases (potential activator of CLEC-16A via modulation of phosphatase activity). | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylyl cyclase, increasing cAMP levels (may activate CLEC-16A through the cAMP-dependent pathway). | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Facilitates calcium ion transport across membranes (potential activator of CLEC-16A through calcium-dependent signaling). | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC) (may activate CLEC-16A by modulating PKC-dependent signaling pathways). | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Inhibitor of NF-κB activation (potential activator of CLEC-16A through modulation of NF-κB signaling). | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $251.00 $500.00 $547.00 | 16 | |
Inhibitor of Janus kinases (JAKs) (may activate CLEC-16A through regulation of the JAK/STAT pathway). | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
Selective GSK-3 inhibitor (potential activator of CLEC-16A through modulation of GSK-3 activity). | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Ser/Thr phosphatase inhibitor (may activate CLEC-16A through regulation of phosphatase activity). | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
Cell-permeable cAMP analog (potential activator of CLEC-16A through activation of cAMP-dependent pathways). | ||||||